Generic drugs were introduced decades ago as a free-market alternative to expensive name brands, in contrast to Europe’s government-negotiated system. But although we assume generic versions are identical to their name-brand counterparts, they can differ in important ways. And as the price of generics has spiked, legislators and others are questioning the role of this multibillion-dollar industry in our health care system.

Guests

  • Jeremy Greene MD; Professor of Medicine and the History of Medicine, Johns Hopkins University School of Medicine; Author, “Generic: The Unbranding of Modern Medicine.”

Related Links

Topics + Tags

Comments

comments powered by Disqus
Most Recent Shows

The Politics Hour – March 22, 2019

Friday, Mar 22 2019We tackle the biggest political news of the week, from the reprimand of a D.C. Councilmember to Governor Larry Hogan calling the Maryland General Assembly "the most pro-criminal group of legislators" he's ever seen.